Embryonic Stem Cell Therapy and Contemporary Clinical Researches
Posted on January 5, 2009 | Filed Under Uncategorized
1. An individual limited liability company (LLC) embryonic tissue organization EmCell was established in the beginning of 1990-s. EmCell group has been working for fifteen years and got multinational acceptance among the most outstanding clinical experts in the area of investigations and medical application of embryonic stems cells (ESC) in vivo.
2. Today, this really competent and creative crew includes like-minded professionals guided by Prof. Alexander Ivanovich Smikodub who use ESC in vivo, work out indications and contraindications for the treatment of serious acquired and genetic diseases caused by or resulting in cell count decrease.
3. Stem cell treatment of sicknesses
Cell Therapy Clinic of the National Medical University of Ukraine and Embryonic Tissues Center EmCell was founded on September 9, 1994 and has been working for 15 years in spite of changes in legislation and approving of the new by-laws. In all these years, we cured thousands of people from various countries of the world and presented more than 10 000 transplantations of ESC and embryonic tissues. Our means helped save and continue life of hundreds of people, restore various organs and tissues and perform that lots of persons with incurable sicknesses might be aided with stem cell treatment.
In its program aired on November 17, 2005, BBC called our facility the Last Hope Clinic because for 15 years we treated and followed-up the most complex clinical occasions. You can also see that our hospital offers effective averting and anti-aging programs.
4. Biotechnology of stem cell isolation and storage
The techniques of stem cell isolation and storage are practiced by EmCell and clinic experts. These means were patented in various countries of the world, including USA and the Netherlands. They make embryonic cell suspensions, test them and use them for clinical aims, therefore each expert includes working in sterile box with clinical practice. Our opinion is that transplant of materials that are made at the center to the patient is the best variant.
Different biotechnological steps of operating with the material of stem cells:
1. Timely, safe, and ethically approved range of great quality embryonic matter in gynecological departments;
2. The following stage is preparing of cell materials and inserting them into abacterial containers;
3. Testing of embryonic cell suspensions in safety and viability atmosphere;
4. Cryopreservation of embryonic materials at very low temperatures;
5. Examination of embryonic cell suspensions after defrosting;
6. The last step is long-term storing of embryonic cell materials in cryobank.
5. Cell matter bank
Stem material bank has always been a significant question for EmCell: up-to-date containers and boxes containing more than 10 000 embryonic, fetal, cord blood cell suspensions as well as human and experimental animal materials. Periodic examinations for bacteria and fungi are made for all those boxes and media.